Skip to main content
Erschienen in: European Journal of Epidemiology 1/2012

01.01.2012 | CANCER

Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005

verfasst von: Shan Gao, Wan-Shui Yang, Freddie Bray, Puthiery Va, Wei Zhang, Jing Gao, Yong-Bing Xiang

Erschienen in: European Journal of Epidemiology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

In China, hepatocellular carcinoma (HCC) incidence rates in several registry catchment populations are amongst the highest worldwide. The incidence rates in urban Shanghai were analyzed between 1976 and 2005 to describe and interpret the time trends. Age-specific and age-standardized rates were calculated and graphically presented. An age-period-cohort model was fitted to assess the effects of age at diagnosis, calendar period, and birth cohort on the changing HCC incidence rates. In total, 35,241 and 13,931 men and women were diagnosed with HCC during 1976–2005 in urban Shanghai. The age-standardized incidence rates in urban Shanghai were 33.9 per 105 among men and 11.4 per 105 among women in 1976–1980, but decreased in both sexes to 25.8 per 105 and 8.5 per 105, respectively by 2001–2005. Accelerating rates in birth cohorts born in the early-1930s and decelerating rates circa 1945 were observed in both sexes, with further accelerations noted in the late-1950s (in women) and early-1960s (in men). Given the parameterization, increases in risk of HCC were seen in successive male and female generations between 1900 and 1935, followed by a further increase among successive cohorts born around 1960, with a reduction in risk in the most recent generations. The incidence rates of HCC in urban Shanghai from 1976 to 2005 have declined in both sexes, with the complex but similar patterns observed in successive generations suggestive of a shared changing prevalence in risk factors in men and women, with a role possibly for HBV interventions reducing risk of HCC in cohorts born after 1960.
Literatur
2.
Zurück zum Zitat Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007. vol. 160, pp. 1–897. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007. vol. 160, pp. 1–897.
3.
Zurück zum Zitat International Agency for Research on Cancer. Cancer incidence in five continents. 2010 [Internet] [cited 2010 December 3]. Available from URL: http://ci5.iarc.fr/. International Agency for Research on Cancer. Cancer incidence in five continents. 2010 [Internet] [cited 2010 December 3]. Available from URL: http://​ci5.​iarc.​fr/​.
4.
Zurück zum Zitat The Shanghai Cancer Registry. The incidence rates of malignant tumors in urban Shanghai, 2007. Tumor (Shanghai) 2010;30:726. The Shanghai Cancer Registry. The incidence rates of malignant tumors in urban Shanghai, 2007. Tumor (Shanghai) 2010;30:726.
5.
Zurück zum Zitat Clayton D, Schifflers E. Models for temporal variation in cancer rates I: age-period and age-cohort models. Stat Med. 1987;6(4):449–67.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates I: age-period and age-cohort models. Stat Med. 1987;6(4):449–67.PubMedCrossRef
6.
Zurück zum Zitat Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age- period- cohort models. Stat Med. 1987;6(4):469–81.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age- period- cohort models. Stat Med. 1987;6(4):469–81.PubMedCrossRef
7.
Zurück zum Zitat Lee LT, Huang HY, Huang KC, Chen CY, Lee WC. Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976–2005. Ann Epidemiol. 2009;19(5):323–8.PubMedCrossRef Lee LT, Huang HY, Huang KC, Chen CY, Lee WC. Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976–2005. Ann Epidemiol. 2009;19(5):323–8.PubMedCrossRef
8.
Zurück zum Zitat Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, Vercelli M, De Lisi V, Tagliabue G, Federico M, Falcini F, Cassetti T, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285–92.PubMedCrossRef Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, Vercelli M, De Lisi V, Tagliabue G, Federico M, Falcini F, Cassetti T, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285–92.PubMedCrossRef
9.
Zurück zum Zitat Gao YT, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007. p. 443. Gao YT, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007. p. 443.
10.
Zurück zum Zitat Carstensen B. Age-period cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018–45.PubMedCrossRef Carstensen B. Age-period cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018–45.PubMedCrossRef
11.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon, France: IARC Science Publication; 2002. vol. 155, pp. 1–781. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon, France: IARC Science Publication; 2002. vol. 155, pp. 1–781.
12.
Zurück zum Zitat Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Cause Control. 2000;11(1):31–5.CrossRef Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Cause Control. 2000;11(1):31–5.CrossRef
13.
Zurück zum Zitat Viel JF, Fournier E, Danzon A. Age-period-cohort modeling of non-Hodgkin’s lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health. 2010;9:47.PubMedCrossRef Viel JF, Fournier E, Danzon A. Age-period-cohort modeling of non-Hodgkin’s lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health. 2010;9:47.PubMedCrossRef
14.
Zurück zum Zitat Zong ZH, Shen QJ, Chen JG, Li WG, Yao HY. Application of Bayesian graphical modeling to analysis of the incidence data of primary liver cancer in Qidong county. Chin J Health Stat. 2005;22:13–5. Zong ZH, Shen QJ, Chen JG, Li WG, Yao HY. Application of Bayesian graphical modeling to analysis of the incidence data of primary liver cancer in Qidong county. Chin J Health Stat. 2005;22:13–5.
15.
Zurück zum Zitat Shen QJ, Zhang XF, Chen JG, Li WG, Yao HY. An age-period-cohort modeling study on primary liver cancer incidence rate in Qidong. Clin J Epidemiol. 2004;25:902–4. Shen QJ, Zhang XF, Chen JG, Li WG, Yao HY. An age-period-cohort modeling study on primary liver cancer incidence rate in Qidong. Clin J Epidemiol. 2004;25:902–4.
16.
Zurück zum Zitat R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2010. ISBN 3-900051-07-0. [Internet] 2010 [cited 2010 December 3]. Available from: http://www.R-project.org. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2010. ISBN 3-900051-07-0. [Internet] 2010 [cited 2010 December 3]. Available from: http://​www.​R-project.​org.
18.
Zurück zum Zitat Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9–14. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9–14.
19.
Zurück zum Zitat Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes. Hepatology. 2008;47(6):1856–62.PubMedCrossRef Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes. Hepatology. 2008;47(6):1856–62.PubMedCrossRef
20.
Zurück zum Zitat Lu F, Zhuan H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J. 2009;122:2925–7.PubMed Lu F, Zhuan H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J. 2009;122:2925–7.PubMed
21.
Zurück zum Zitat Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31(6):1243–8.PubMedCrossRef Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31(6):1243–8.PubMedCrossRef
22.
Zurück zum Zitat Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.PubMedCrossRef Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.PubMedCrossRef
23.
Zurück zum Zitat Li YT, Wu HY, Zhang AX, Shen WJ, Yuan GJ. Epidemiological effect observed after hepatitis B immunization of newborns in different regions in Shanghai. Shanghai J Prev Med. 2000;12:410–1. Li YT, Wu HY, Zhang AX, Shen WJ, Yuan GJ. Epidemiological effect observed after hepatitis B immunization of newborns in different regions in Shanghai. Shanghai J Prev Med. 2000;12:410–1.
24.
Zurück zum Zitat Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90–1. Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90–1.
25.
Zurück zum Zitat Zhang AX, Li YT, Xu Q, et al. Review and measures of hepatitis B immunization in Shanghai. Shanghai J Prev Med. 2000;12:408–10. Zhang AX, Li YT, Xu Q, et al. Review and measures of hepatitis B immunization in Shanghai. Shanghai J Prev Med. 2000;12:408–10.
26.
Zurück zum Zitat Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and the development of hepatocellular carcinoma. Liver. 1995;15(3):159–63.PubMed Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and the development of hepatocellular carcinoma. Liver. 1995;15(3):159–63.PubMed
27.
Zurück zum Zitat Zhao SJ, Xu ZY, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol. 2000;29(4):744–52.PubMedCrossRef Zhao SJ, Xu ZY, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol. 2000;29(4):744–52.PubMedCrossRef
28.
Zurück zum Zitat Lu W, Li DL, Zheng Y. Conception of cancer prevention and control strategy in Shanghai. China Cancer. 2001;10:187–8. Lu W, Li DL, Zheng Y. Conception of cancer prevention and control strategy in Shanghai. China Cancer. 2001;10:187–8.
29.
Zurück zum Zitat Wang J, Liu XM. Assessment of dietary aflatoxins exposure in Chinese residents. Chin J Food Hygiene. 2007;19(3):238–40. Wang J, Liu XM. Assessment of dietary aflatoxins exposure in Chinese residents. Chin J Food Hygiene. 2007;19(3):238–40.
30.
Zurück zum Zitat Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986;47:297–329.CrossRef Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986;47:297–329.CrossRef
31.
Zurück zum Zitat China Cancer Prevention and Treatment Office. The diagnostic standard on primary liver cancer. Chin J Hepato Surg. 1998;4:103. China Cancer Prevention and Treatment Office. The diagnostic standard on primary liver cancer. Chin J Hepato Surg. 1998;4:103.
32.
Zurück zum Zitat Keyes KM, Utz RL, Robinson W, Li GH. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006. Soc Sci Med. 2010;70(7):1100–8.PubMedCrossRef Keyes KM, Utz RL, Robinson W, Li GH. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006. Soc Sci Med. 2010;70(7):1100–8.PubMedCrossRef
33.
Zurück zum Zitat Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiological heterogeneity for cervical carcinoma by histopathological type, using comparative age-period-cohort (APC) models. Cancer Epidemiol Biomarkers Prev. 2009;18(3):792–800.PubMedCrossRef Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiological heterogeneity for cervical carcinoma by histopathological type, using comparative age-period-cohort (APC) models. Cancer Epidemiol Biomarkers Prev. 2009;18(3):792–800.PubMedCrossRef
34.
Zurück zum Zitat Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.PubMedCrossRef Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.PubMedCrossRef
35.
Zurück zum Zitat Gao S, Yang WS, Gao J, Wang J, Xiang YB. A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer. Chin J Prev Med. 2010;44(8):711–6. Gao S, Yang WS, Gao J, Wang J, Xiang YB. A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer. Chin J Prev Med. 2010;44(8):711–6.
36.
Zurück zum Zitat Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef
37.
Zurück zum Zitat Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127(5 Suppl 1):S17–26.PubMedCrossRef Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127(5 Suppl 1):S17–26.PubMedCrossRef
38.
Zurück zum Zitat Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control. 2006;17(7):901–9.PubMedCrossRef Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control. 2006;17(7):901–9.PubMedCrossRef
39.
Zurück zum Zitat Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17(4):846–54.PubMedCrossRef Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17(4):846–54.PubMedCrossRef
Metadaten
Titel
Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005
verfasst von
Shan Gao
Wan-Shui Yang
Freddie Bray
Puthiery Va
Wei Zhang
Jing Gao
Yong-Bing Xiang
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 1/2012
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9636-8

Weitere Artikel der Ausgabe 1/2012

European Journal of Epidemiology 1/2012 Zur Ausgabe